Lucier Gregory T

Invitrogen Corp.

Chief Executive Officer, Director

Avg. Two Year Performance

78% Avg. Purchase Return 33% Compound

4% Avg. Sale Return 2% Compound

Holdings: 0 shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Medical Laboratories & Research

Health Services

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions